Venture Capital Alamar Biosciences Closes $80 Million Series B FREMONT — Alamar Biosciences, Inc., a precision proteomics company that brings both ultra-high sensitivity and… EditorSeptember 8, 2021
Venture Capital Checkr Checks In With $250 Million Series E SAN FRANCISCO – Checkr, a leading a provider of employee background checks, has raised $250 million in… EditorSeptember 8, 2021